|
Efficacy and safety of darbepoetin alpha in patients with myelodysplastic syndromes: a systematic review and meta-analysis
|
May 2016
|
Br J Haematol
|
myelodysplastic syndromes (MDS)
|
|
Efficacy and safety of deferasirox in myelodysplastic syndromes
|
Feb 2013
|
Ann Hematol
|
myelodysplastic syndromes (MDS)
|
|
Efficacy and safety of eculizumab in children and adolescents with paroxysmal nocturnal hemoglobinuria
|
Apr 2014
|
Pediatr Blood Cancer
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Efficacy and safety of extended dosing schedules of CC-486 (oral azacitidine) in patients with lower-risk myelodysplastic syndromes
|
Oct 2015
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
Efficacy and Safety of Lenalidomide for Treatment of Low-/Intermediate-1-Risk Myelodysplastic Syndromes with or without 5q Deletion: A Systematic Review and Meta-Analysis
|
Nov 2016
|
PLoS One
|
myelodysplastic syndromes (MDS)
|
|
Efficacy of rabbit antithymocyte globulin as first-line treatment of severe aplastic anemia: an Asian multicenter retrospective study
|
Jul 2016
|
Int J Hematol
|
aplastic anemia
|
|
Efficacy, safety, and pharmacokinetics of subcutaneous azacitidine in Taiwanese patients with higher-risk myelodysplastic syndromes
|
Jan 2017
|
Asia Pac J Clin Oncol
|
myelodysplastic syndromes (MDS)
|
|
Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia
|
Apr 2017
|
N Engl J Med
|
aplastic anemia
|
|
Eltrombopag and improved hematopoiesis in refractory aplastic anemia
|
Jul 2012
|
N Engl J Med
|
aplastic anemia
|
|
Eltrombopag for refractory severe aplastic anemia: dosing, duration, long term outcomes and clonal evolution
|
Apr 2019
|
Blood
|
aplastic anemia
|
